Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

A MUM was given just a week to live after doctors found a tumour that had been silently lurking in her brain for more than a decade. Harriet Annabelle Ward occasionally felt dizzy and tired but ...

They studied 36 FFPE samples from patients with meningioma – a common and benign brain tumor – and used a novel computational approach to integrate this data with nearly 1,300 publicly ...

Researchers at Fred Hutch and MD Anderson discovered RNA Polymerase II on histone genes as a biomarker for cancer ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...

They studied 36 FFPE samples from patients with meningioma—a common and benign brain tumor—and used a novel computational approach to integrate this data with nearly 1,300 publicly available ...